Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000040453
JPRN-UMIN000040453Completed未知

ong-term follow-up of corona virus disease 2019 (COVID-19) antibody seroprevalence in the cohort of employees at hospitals with or without cluster of COVID-19. - Long-term follow-up of COVID-19 antibody seroprevalence in the cohort of medical staff.

Daini Osaka Police Hospital0 sites45 target enrollmentStarted: May 25, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
45
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Person who don't want to participate the study

Investigators

Similar Trials

Recruiting
Not Applicable
ong-term follow-up post SARS-CoV-2 / COVID-19 infection (SARS-CoV-2-Follow-Up)U09.9Post COVID-19 condition, unspecified
DRKS00025089niversitätsklinikum Heidelberg500
Active, not recruiting
Not Applicable
A long-term follow-up study of patients with coronavirus (COVID-19) associated pneumoniaCOVID-19 pneumonia, COVID-19 (SARS-CoV-2 infection)Infections and Infestations
ISRCTN11265821Genentech, Inc300
Recruiting
Unknown
ong-term Follow-up Cohort Study for COVID-19 Patients in KoreaCodes for special purposes
KCT0008573Korea University Ansan Hospital100
Completed
Not Applicable
ong-term functional prognostic study of Coronavirus disease - 2019 (COVID-19) infectioCoronavirus disease - 2019(COVID-19) infection
JPRN-UMIN000045578Kitasato university270
Unknown
Not Applicable
Long-term Outcomes in Patients With COVID-19COVID-19
NCT04508712RenJi Hospital900